.svg){kind=icon}
.svg){kind=icon}
Enduring
relationships
Grow With Us… We’re In for the Long Haul
- Anti Bribery and Anti Corruption Policy
- Authorization for Determination of Materiality of Events or Information
- Board Diversity Policy
- Code of Conduct for Directors and Senior Management
- Code of practices and procedures for fair disclosure of UPSI
- Code of conduct for regulating, monitoring and reporting of trading by insiders
- CSR Policy
- Dividend Distribution Policy
- Familiarisation program for Independent Directors
- Investor Grievance Redressal Policy
- LatentView Analytics Ltd_Materiality Policy
- Policy on Archival of Documents
- Policy for determination of matriality of events or information
- Policy on Material Subsidiaries
- Policy on preservation of documents
- Risk Management Policy
- LatentView Related Party Transaction Policy
- Nomination and Remuneration Policy
- Model Independent Director Appointment Letter
- Policy for Procedure of Inquiry in case of leak of UPSI or suspected leak of UPSI
- Sustainable Procurement Policy
- The Policy For Prevention, Prohibition And Redressal Of Sexual Harassment At Workplace
- Whistle Blower Policy
- Compliance Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 September 2024
Postal Ballot
..
Annual General Meeting
2021-2022
2022-2023
2023-2024
Inspection of Documents
Announcements to Stock exchanges
2025 - 2026
2024 - 2025
2023 - 2024
2022 - 2023
2021 - 2022
2025 - 2026
2024 - 2025
- BM Intimation for approval of Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2024
- Compliance Certificate in terms of Regulation 40 of SEBI(LODR) Regulation, 2015 March 2024
- Compliance Certificate pursuant to Regulation 7(3) of SEBI(LODR) Regulations, 2015 March 2024
- Compliance Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018_March 2024
- Statement of Investor Complaints for the quarter ended March 2024
- Regulation 30 – Change in Senior Management Personnel of the Company
- Disclosure of Related Party Transactions for the half year ended March 31, 2024
- Intimation for Allotment of 93,861 equity shares under the Employee Stock Option Plan
- Monitoring Agency Report for quarter ended March 2024
- Statement of Deviation for the quarter ended March 2024
- Analyst Meet Intimation – June 17, 2024 – 1
- Analyst Meet Intimation – June 17, 2024 – 2
- Analyst Meet Intimation – June 18, 2024 – 1
- Analyst Meet Intimation – June 18, 2024 – 2
- Analyst Meet Intimation – June 19, 2024
- Analyst Meet Intimation – June 20, 2024
- Analyst Meet Intimation – June 21, 2024
- Analyst Meet Intimation – June 25, 2024
- BM Intimation for Approval Of Unaudited Standalone & Consolidated Financial Results For Quarter Ended June 30, 2024
- Intimation for Closure of Trading Window June 2024
- Analyst Meet Intimation – June 26, 2024
- Announcement under Regulation 30 – Update on Acquisition – July 01, 2024
- Compliance Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 June 2024
- Statement of Investor Complaints for the quarter ended June 2024
- Re-appointment of Internal Auditors of the Company for the financial year 2024-2025
- Monitoring Agency Report for quarter ended June 2024
- Statement of Deviation for the quarter ended June 2024
- Public Notice regarding the 18th AGM
- Analyst Meet Intimation – August 20, 2024
- Analyst Meet Intimation – August 21, 2024
- Analyst Meet Intimation – August 26, 2024
- Regulation 30 – Change in Senior Management Personnel of the Company
- Appointment of Statutory Auditor
- Analyst Meet Intimation – September 05, 2024
- Analyst Meet Intimation – September 20, 2024
- Analyst Meet Intimation – September 25, 2024
- BM Intimation for Approval Of Unaudited Standalone & Consolidated Financial Results For Quarter Ended September 30, 2024
- Intimation for Closure of Trading Window September 2024
- Statement of Investor Complaints for the quarter ended September 2024
- Disclosure of Related Party Transactions for the half year ended September 30, 2024
- Re-appointment of Secretarial Auditors of the Company for the financial year 2024-2025
- Investor Day – November 11, 2024
- Regulation 30 – Appointment of Ms. Remadevi Thottathil, Senior Management Personnel
- Analyst Meet Intimation – November 20, 2024
- Analyst Meet Intimation – November 29, 2024
- Intimation for Allotment of 4,73,608 equity shares under the ESOP
- Analyst Meet Intimation – December 09, 2024
- Analyst Meet Intimation – December 04, 2024
- Analyst Meet Intimation – December 11, 2024
- Analyst Meet Intimation – December 12, 2024
- Analyst Meet Intimation – December 13, 2024
- Statement of Investor Complaints for the quarter ended December 2024
- BM Intimation for Approval Of Unaudited Standalone & Consolidated Financial Results For Quarter and Nine Months Ended December 31 2024
- Compliance Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 December 2024
- Unaudited Financial Results(Both Standalone And Consolidated) For The Quarter And Nine Months Ended December 31, 2024
- Analyst Meet Intimation – February 11, 2025
- Analyst Meet Intimation – February 19, 2025
- Analyst Meet Intimation – February 24, 2025
- Analyst Meet Intimation – February 28, 2025
- Analyst Meet Intimation – March 06 and 07, 2025
- Analyst Meet Intimation – March 10, 2025
- Analyst Meet Intimation – March 11, 2025
- Analyst Meet Intimation – March 20, 2025
- Analyst Meet Intimation – March 24, 2025
- Intimation for Trading window closure – March 31, 2025
- BM Intimation for Approval Of Audited Standalone & Consolidated Financial Results For Quarter and Financial Year Ending – March 31 2025
2023 - 2024
- Compliance Certificate In Terms Of Regulation 40 Of SEBI (LODR) Regulations, 2015 March 2023
- Compliance Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018_March 2023
- Statement Of Investor Complaints For The Quarter Ended March 2023
- Compliance Certificate pursuant to Regulation 7 (3) of SEBI (LODR) Regulations, 2015_March 2023
- Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financial Results for the Quarter And Year Ended On March 31, 2023
- Analyst Meet Intimation – May 17, 2023
- Disclosure of Related Party Transactions for the half year ended March 31, 2023
- Statement of Deviation for quarter ended March 2023
- Monitoring Agency Report for quarter ended March 2023
- Analyst Meet Intimation – June 09, 2023
- Analyst Meet Intimation – June 12, 2023
- Analyst Meet Intimation – June 12, 2023
- Board Meeting Intimation for Approval Of Unaudited Standalone & Consolidated Financial Results For The Quarter Ended June 30, 2023
- Analyst Meet Intimation – June 19, 2023
- Analyst Meet Intimation – June 19, 2023
- Analyst Meet Intimation – June 27, 2023
- Reschedule of Analyst Meet Intimation – June 27, 2023
- Intimation for closure of Trading Window June 30, 2023
- Intimation of Book Closure for the 17th Annual General Meeting
- Compliance Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 June 2023
- Statement Of Investor Complaints For The Quarter Ended June 2023
- Statement of Deviation for the quarter ended June, 2023
- Monitoring Agency Report for the quarter ended June, 2023
- Analyst Meet Intimation – August 10, 2023
- Analyst Meet Intimation – August 08, 2023
- Analyst Meet Intimation – August 11, 2023
- Analyst Meet Intimation – August 16, 2023
- Analyst Meet Intimation – August 17, 2023
- Analyst Meet Intimation – August 28, 2023
- Analyst Meet Intimation – August 29, 2023
- Analyst Meet Intimation – September 04, 2023
- Analyst Meet Intimation – September 05, 2023
- Analyst Meet Intimation – September 11, 2023
- BM Intimation for Approval Of Unaudited Standalone & Consolidated Financial Results For The Quarter & Half Year Ended Sept 30, 2023
- Intimation for Closure of trading window September 30, 2023
- Analyst Meet Intimation – September 20, 2023
- Statement of Investor Complaints for the quarter ended September 2023
- Compliance Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 September 2023
- Disclosure of Related Party Transactions for The Half Year Ended September 30, 2023
- Analyst Meet Intimation – November 01, 2023
- Analyst Meet Intimation – November 03, 2023
- Analyst Meet Intimation – November 06, 2023
- Analyst Meet Intimation – November 08, 2023
- Monitoring Agency Report for the quarter ended September, 2023
- Statement of Deviation for the quarter ended September, 2023
- Analyst Meet Intimation – November 09, 2023
- Analyst Meet Intimation – November 10, 2023
- Analyst Meet Intimation – November 14, 2023
- Intimation for Allotment of 10,02,445 equity shares under the Employee Stock Option
- Analyst Meet Intimation – December 11, 2023
- BM Intimation for approval of Unaudited Standalone & Consolidated Financial Results for the quarter & nine months ending December 31, 2023
- Intimation for Closure of trading window December 31, 2023
- Intimation under regulation 30(4) read with Para B of Part A of Schedule III of SEBI (LODR) Regulations, 2015
- Compliance Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 December 2023
- Statement of Investor Complaints for the quarter ended December 2023
- Monitoring Agency Report for the quarter ended December, 2023
- Statement of Deviation for the quarter ended December, 2023
- Analyst Meet Intimation – February 28, 2024
- Analyst Meet Intimation – March 20, 2024
- Intimation for closure of Trading window March 31, 2024
- Analyst Call Intimation – March 28, 2024
- Announcement under Regulation 30 – Acquisition
- Analyst Call Recording – March 28, 2024
- Announcement under Regulation 30 – Update on Acquisition
- Analyst Call Transcript – March 28, 2024
2022 - 2023
- Announcement under Regulation 30 (LODR)-Analyst – Investor Meet – June 17, 2022
- Announcement under Regulation 30 (LODR)-Analyst – Investor Meet – June 21, 2022
- Announcement under Regulation 30 (LODR)-Analyst – Investor Meet – June 29, 2022
- Announcement under Regulation 30 (LODR)-Analyst – Investor Meet – June 30, 2022
- Statement Of Investor Complaints For The Quarter Ended June 2022
- Board meeting intimation for approval of the Unaudited financial statements of the company for the quarter ended June 30, 2022
- Intimation of closure of Trading Window
- Intimation of Book closure for the 16th Annual General Meeting
- Intimation of Schedule of Analyst Institutional Investor Meeting – August 03, 2022
- Intimation of Schedule of Analyst Institutional Investor Meeting – August 05, 2022
- Intimation of Schedule of Analyst Institutional Investor Meeting – August 11, 2022
- Announcement under Regulation 30 (LODR)-Monitoring Agency Report-June 30,2022
- Disclosure under Regulation 32(1) of SEBI LODR Regulations – June 30,2022
- Intimation of Schedule of Analyst Institutional Investor Meeting – August 18, 2022
- Intimation of Schedule of Analyst Institutional Investor Meeting – August 29, 2022
- Intimation of Schedule of Analyst Institutional Investor Meeting – September 14, 2022
- Intimation of Schedule of Analyst Institutional Investor Meeting – September 29,2022
- Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended On September 30, 2022
- Statement of Investor Complaints for the quarter ended September 30, 2022
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Announcement under Regulation 30 (LODR)- Grant of ESOP
- Announcement under Regulation 30 (LODR)-Analyst – Investor Meet – November 1, 2022
- Disclosure Of Related Party Transactions For The Half Year Ended September 30, 2022
- Disclosure Under Regulation 32(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
- Announcement under Regulation 30 (LODR)-Monitoring Agency Report September 2022
- Announcement under Regulation 30 (LODR)-Analyst – Investor Meet – November 3, 2022
- Announcement under Regulation 30 (LODR)-Analyst – Investor Meet – November 7, 2022
- Announcement under Regulation 30 (LODR)-Analyst – Investor Meet – November 11, 2022
- Intimation for Allotment of 27,12,019 equity shares under the Employee Stock Option
- Announcement under Regulation 30 (LODR)-Analyst – Investor Meet – November 23, 2022
- Announcement under Regulation 30 (LODR)-Analyst – Investor Meet – November 24, 2022
- Announcement under Regulation 30 (LODR)-Analyst – Investor Meet – November 30, 2022
- Announcement under Regulation 30 (LODR)-Analyst – Investor Meet – December 06, 2022
- Announcement under Regulation 30 (LODR)-Analyst – Investor Meet – December 20 & 21, 2022
- Intimation for closure of Trading Window
- Announcement under Regulation 30 (LODR)-Analyst – Investor Meet – December 23, 2022
- Board meeting intimation for approval of the Unaudited financial statements of the company for the quarter ended December 31, 2022
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 – December 2022
- Statement Of Investor Complaints For The Quarter Ended December 2022
- Announcement under Regulation 30 (LODR)-Monitoring Agency Report December 2022
- Disclosure under Regulation 32(1) of SEBI LODR Regulations December 2022
- Announcement under Regulation 30 (LODR)-Analyst – Investor Meet – February 14, 2023
- Announcement under Regulation 30 (LODR)-Analyst – Investor Meet – March 1, 2023
- Announcement under Regulation 30 (LODR)-Analyst – Investor Meet – March 8, 2023
- Announcement under Regulation 30 (LODR)-Analyst – Investor Meet – March 16, 2023
- Announcement under Regulation 30 (LODR)-Analyst – Investor Meet – March 20, 2023
- Announcement under Regulation 30 (LODR)-Analyst – Investor Meet – March 21 & 22, 2023
- Intimation for Allotment of 17,67,489 equity shares under the Employee Stock Option
- Intimation for closure of Trading Window March 31, 2023
2021 - 2022
- Intimation of Schedule of Analyst Institutional Investor Meeting
- Intimation of closure of Trading Window
- Certificate in terms of regulation 74(5) of SEBI (Depositories and Participants)
- Intimation of Board Meeting
- Intimation of Schedule of Earnings Call
- Outcome of the Board Meeting held on February 08, 2022
- Disclosure under Regulation 32(1) of SEBI LODR Regulations
- Announcement under Regulation 30 (LODR)-Monitoring Agency Report
- Announcement under Regulation 30 (LODR)-Analyst – Investor Meet – Outcome
- Announcement under Regulation 30 (LODR)-analyst – Investor Meet – Feb 16, 2022
- Announcement under Regulation 30 (LODR)-Analyst – Investor Meet – Feb 17, 2022
- Announcement under Regulation 30 (LODR)-Analyst – Investor Meet – Feb 18, 2022
- Announcement under Regulation 30 (LODR)-Analyst – Investor Meet – Feb 23, 2022
- Board meeting intimation for approval of the audited financial statements of the company for the quarter and financial year ended march 31, 2022
- Compliance Certificate In Terms Of Regulation 40 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
- Statement Of Investor Complaints For The Quarter Ended March 2022
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Compliance Certificate Pursuant To Regulation 7 (3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
- Format of Initial Disclosure to be made by an entity identified as a Large Corporate
- Disclosure under Regulation 32(1) of SEBI LODR Regulations
- Announcement under Regulation 30 (LODR)-Monitoring Agency Report
- Intimation of Schedule of Earnings Call – Q4FY22 & FY22
- Reporting on violation of Code of Conduct under SEBI (Prohibition of Insider Trading) Regulations, 2015
- Disclosure of Related Party Transactions for the half year ended March 31, 2022
Material Creditors
Press release
Newspaper Advertisements
2021-2022
2022-2023
- Public Notice regarding the 16th AGM
- Q1 FY23 Unaudited Financial Results
- Q2 FY23 Unaudited Financial Results
- Q3 FY23 Unaudited Financial Results
- Q4 FY23 Newspaper Advertisement
2023-2024
- Q1 FY24 Newspaper Advertisement
- Q2 FY24 Newspaper Advertisement
- Q3 FY24 Newspaper Advertisement
- Q4 FY24 Newspaper Advertisement
